Sibutramine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01105 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypervitaminosis | KG + DL |
| 2 | proximal 16p11.2 microdeletion syndrome | KG + DL |
| 3 | obsolete hypertelorism (disease) | KG + DL |
| 4 | frontorhiny | KG + DL |
| 5 | pentosuria | KG + DL |
| 6 | postural orthostatic tachycardia syndrome | KG + DL |
| 7 | lethal polymalformative syndrome, Boissel type | KG + DL |
| 8 | fatty liver disease | KG + DL |
| 9 | migraine disorder | KG + DL |
| 10 | migraine with brainstem aura | KG + DL |
| 11 | non-alcoholic steatohepatitis | KG + DL |
| 12 | benign paroxysmal torticollis of infancy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.